Years of research & clinician collaboration show that reliable closure is essential—but only part of the solution. AtriClip’s fabric cover helps protect surrounding anatomy & supports tissue ingrowth for acute and long-term stability that mechanical compression alone can’t match.

For 14 years, Gloria lived with Afib. What started as a routine procedure to restore her heart rhythm led to the discovery of a rare cardiac tumor and an opportunity to address both conditions during one procedure.

Using the Cox-Maze IV procedure and AtriCure technologies, Dr. Alphonse DeLucia created precise lines of scar tissue designed to interrupt the abnormal electrical signals that cause Afib and help restore normal sinus rhythm.

Today, Gloria is back to walking her garden without losing her breath and looking ahead to celebrating her 70th birthday. Stories like hers highlight the impact surgical Afib treatment can have on patients’ lives.

Watch the full story: <a href="https://okt.to/voLItF&quot; target="_blank">https://okt.to/voLItF</a&gt;

Strong recovery starts with effective pain management.

We brought together surgeons, anesthesia providers, APPs &amp; nursing teams to explore multimodal perioperative pain strategies, including the role of Cryo Nerve Block. Thanks to all who joined!

Upcoming courses:

The EnCompass clamp uses a magnetic guide to streamline placement through the heart’s natural sinuses—helping reduce extensive dissection and support smoother navigation through cardiac anatomy.

More efficiency. Less disruption.

Learn more: <a href="https://t.co/UpfiavTd8V&quot; target="_blank">https://t.co/UpfiavTd8V</a&gt;

<a href="https://twitter.com/hashtag/Ablation?src=hashtag_click&quot; target="_blank">#Ablation</a>

The Isolator® Synergy™ EnCompass® clamp and AtriClip FLEX-Mini® device offer surgeons the confidence to perform open cardiac surgery with precision and efficiency.

A more comprehensive strategy for CABG patients.
Learn more: <a href="https://t.co/OAG2tIareG&quot; target="_blank">https://t.co/OAG2tIareG</a&gt;

<a href="https://twitter.com/hashtag/CABG?src=hashtag_click&quot; target="_blank">#CABG</a> <a href="https://twitter.com/hashtag/Ablation?src=hashtag_click&quot; target="_blank">#Ablation</a>

The LAA is the leading source of stroke-causing clots in Afib. Backed by randomized clinical trial evidence and a Class IA guideline recommendation, LAAE is a critical step in reducing stroke risk when treating Afib during cardiac surgery.

Learn why: <a href="https://t.co/hS9NTYgksm&quot; target="_blank">https://t.co/hS9NTYgksm</a&gt;

The EPi-Sense family is the first and only FDA-approved set of devices for minimally invasive ablation therapy to treat LSPAF—the most prevalent and undertreated Afib patient population.​

Discover the EPi-Sense ST™ device: <a href="https://t.co/D1OB0qcGpk&quot; target="_blank">https://t.co/D1OB0qcGpk</a&gt; ​

<a href="https://twitter.com/hashtag/CardioTwitter?src=hashtag_click&quot; target="_blank">#CardioTwitter</a>

We celebrate our employees at All Employee Meetings with the Heart of AtriCure Award. This award is one way we recognize employees who embody our values while demonstrating exceptional performance on behalf of each other, our patients and our partners. Congratulations to our recipients Andy, Brianna, Cameron, Patrick, Rod and Phil.

Congratulations to Dr. Ziazadeh and the <a href="https://twitter.com/UR_Med&quot; target="_blank">@UR_Med</a> team on treating their 25th patient with Hybrid AF™ Therapy. Through a collaborative surgical and EP approach, they continue expanding access to advanced treatment options for patients with LSPAF. Learn more:

Medications and rhythm control can help manage symptoms, but they don’t cure Afib. As a progressive disease, treating symptoms alone may leave patients at ongoing risk.